您的浏览器禁用了JavaScript(一种计算机语言,用以实现您与网页的交互),请解除该禁用,或者联系我们。[美股财报]:IDEX Corp 2025年度报告 - 发现报告

IDEX Corp 2025年度报告

2026-02-19美股财报L***
AI智能总结
查看更多
IDEX Corp 2025年度报告

SECURITIES AND EXCHANGE COMMISSIONWashington,D.C. 20549Form10-K ANNUAL REPORT PURSUANT TO SECTION13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 IDEX CORPORATION Indicate by check mark if the registrant is not required to file reports pursuant to Section13 or Section15(d) of the Act.YesNo Indicate by check mark whether the registrant (1)has filed all reports required to be filed by Section13 or 15(d) of the Securities Exchange Act of 1934during the preceding 12months (or for such shorter period that the registrant was required to file such reports), and (2)has been subject to such filingrequirements for the past 90days.YesNoIndicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule405 of RegulationS-T (§232.405 of this chapter) during the preceding 12months (or for such shorter period that the registrant was required to submit suchfiles).YesNoIndicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growthcompany” in Rule 12b-2 of the Exchange Act. Large accelerated filer☑Acceleratedfiler☐Non-accelerated filer☐SmallerreportingcompanyEmerging growthcompany☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new orrevised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internalcontrol over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that preparedor issued its audit report.☑If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.☐Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b).☐Indicate by check mark whether the registrant is a shell company (as defined in Rule12b-2 of the Act).Yes☐No The aggregate market value, as of the last business day of the registrant’s most recently completed second fiscal quarter, of the common stock (based onthe June30, 2025 closing price of $175.57) held by non-affiliates of IDEX Corporation was $13,228,549,364.The number of shares outstanding of IDEX Corporation’s common stock, par value $0.01 per share, as of February13, 2026 was 74,347,824. DOCUMENTS INCORPORATED BY REFERENCEPortions of the proxy statement with respect to the IDEX Corporation 2026 annual meeting of stockholders (the “2026 Proxy Statement”) are incorporated by reference intoPartIIIof this Form10-K. Cautionary Statement Under the Private Securities Litigation Reform Act This annual report on Form 10-K, including the “Overview,” “Results of Operations,” “Liquidity and Capital Resources” and“Management’s Discussion and Analysis of Financial Condition and Results of Operations,” contains “forward-looking” statements withinthe meaning of the Private Securities Litigation Reform Act of 1995, as amended. These statements may relate to, among other things, theCompany’s business strategy, outlook and full year 2026 focus and the assumptions underlying these expectations, capital return strategy,plant and equipment capacity for future growth, planned production, anticipated future acquisition behavior, resource and capital deploymentand focus on organic and inorganic growth, the Company’s ability to adapt to macroeconomic challenges and anticipated adaptability ofresource deployment, anticipated impacts of tariffs and global trade policies and changes in law, including the One, Big, Beautiful Bill Act,the Company’s future market positioning, anticipated trends in end markets, including expectations regarding market sector contraction,recovery, stabilization or growth and underlying drivers of such expectations, expectations regarding future order volumes and order patterns,demand within end markets, availability and sufficiency of cash and financing alternatives, the impacts of any pending or threatened legal,regulatory and other proceedings involving the Company and its subsidiaries, anticipated benefits and restructuring charges, includingseverance charges, related to the Company’s organizational changes, the anticipated tax treatment of the Company’s recent acquisitions, theexpected contingent consideration payable related to th